Evidence map›Paper›PMID 32753974›Full record

ArticleClinical epidemiology2020

Development and Evaluation of a Prediction Model for Ascertaining Rheumatic Heart Disease Status in Administrative Data.

D Bond-Smith, R Seth, N de Klerk, L Nedkoff, M Anderson, J Hung, J Cannon, K Griffiths, J M Katzenellenbogen

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Case Ascertainment on Australian Registers for Acute Rheumatic Fever and Rheumatic Heart Disease.International journal of environmental research and public health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

D Bond-SmithSchool of Population and Global Health, The University of Western Australia, Perth, Australia.ORCID 0000-0002-9415-1314
R SethSchool of Population and Global Health, The University of Western Australia, Perth, Australia.ORCID 0000-0002-3551-6205
N de KlerkSchool of Population and Global Health, The University of Western Australia, Perth, Australia.ORCID 0000-0001-9223-0767
L NedkoffSchool of Population and Global Health, The University of Western Australia, Perth, Australia.
M AndersonQueensland Health, Brisbane, Australia.
J HungSchool of Population and Global Health, The University of Western Australia, Perth, Australia.ORCID 0000-0002-4468-6097
J CannonSchool of Population and Global Health, The University of Western Australia, Perth, Australia.
K GriffithsCentre for Big Data Research, The University of New South Wales, Sydney, Australia.
J M KatzenellenbogenSchool of Population and Global Health, The University of Western Australia, Perth, Australia.ORCID 0000-0001-5287-5819
The University of Western Australia · AUThe Kids Research Institute Australia · AUCharles Darwin University · AUQueensland Health · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious research has raised substantial concerns regarding the validity of the International Statistical Classification of Diseases and Related Health Problems (ICD) codes (ICD-10 I05-I09) for rheumatic heart disease (RHD) due to likely misclassification of non-rheumatic valvular disease (non-rheumatic VHD) as RHD. There is currently no validated, quantitative approach for reliable case ascertainment of RHD in administrative hospital data.

methodsA comprehensive dataset of validated Australian RHD cases was compiled and linked to inpatient hospital records with an RHD ICD code (2000-2018, n=7555). A prediction model was developed based on a generalized linear mixed model structure considering an extensive range of demographic and clinical variables. It was validated internally using randomly selected cross-validation samples and externally. Conditional optimal probability cutpoints were calculated, maximising discrimination separately for high-risk versus low-risk populations.

resultsThe proposed model reduced the false-positive rate (FPR) from acute rheumatic fever (ARF) cases misclassified as RHD from 0.59 to 0.27; similarly for non-rheumatic VHD from 0.77 to 0.22. Overall, the model achieved strong discriminant capacity (AUC: 0.93) and maintained a similar robust performance during external validation (AUC: 0.88). It can also be used when only basic demographic and diagnosis data are available.

conclusionThis paper is the first to show that not only misclassification of non-rheumatic VHD but also of ARF as RHD yields substantial FPRs. Both sources of bias can be successfully addressed with the proposed model which provides an effective solution for reliable RHD case ascertainment from hospital data for epidemiological disease monitoring and policy evaluation.

Indexed as

acute rheumatic feveradministrative dataAustraliacase ascertainmentdiscriminationinternational classification of diseasesnon-rheumatic valvular heart diseasepredictionreceiver operating curverheumatic heart diseasevalidation

Identifiers

PMID32753974
PMCPMC7358074
OpenAlexW3040984115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.